文献速递脑血管病外科神经重症

系统性C反应蛋白可预测动脉瘤性蛛网膜下腔出血后的脑血管痉挛和迟发性脑缺血:一项回顾性观察研究

Systemic C-Reactive Protein Predicts Cerebral Vasospasm and Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Retrospective Observational Study.
PubMed 文献 · World Neurosurg · 2024-09-07

该回顾性观察研究分析了2011年1月至2021年10月杜塞尔多夫大学医院收治的450例动脉瘤性蛛网膜下腔出血患者,入院时检测血清生物标志物。结果显示126例(28.0%)发生脑血管痉挛,123例(27.3%)发生迟发性脑缺血,62例(13.8%)两者兼有;入院CRP升高与上述并发症风险独立相关,且CRP对脑血管痉挛的预测价值(AUC 0.811)高于对迟发性脑缺血的预测价值(AUC 0.690)。

要点

  • 450例aSAH患者中,28.0%发生CVS,27.3%发生DCI,13.8%两者兼有。
  • 发生CVS、DCI或两者兼有的患者入院CRP水平显著高于无并发症者(P < 0.001)。
  • CRP对CVS的预测AUC为0.811,对CVS合并DCI为0.802,对DCI为0.690。

核心结论

  • 入院系统性CRP水平可能是aSAH后发生CVS比发生DCI更有价值的预测指标。
  • 将CRP纳入临床评估可能有助于对高危患者进行风险分层和早期干预策略。

研究设计与样本

  • 回顾性观察研究,纳入2011年1月至2021年10月杜塞尔多夫大学医院收治的450例aSAH患者,入院时检测血清生物标志物。

主要发现

  • 450例患者中,126例(28.0%)发生CVS,123例(27.3%)发生DCI,62例(13.8%)发生CVS合并DCI。
  • 发生CVS、DCI或两者兼有的患者入院CRP水平显著高于无这些并发症的患者(P < 0.001)。
  • 入院CRP升高与CVS、DCI及CVS合并DCI风险增加独立相关(P < 0.05)。
  • CRP对CVS的预测AUC为0.811,对CVS合并DCI的AUC为0.802,对DCI的AUC为0.690。

临床怎么用

  • 作者认为,将CRP纳入临床评估可能有助于对aSAH后CVS和DCI高危患者进行风险分层和早期干预策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is often complicated by cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI), which significantly impact patient outcomes. The study aimed to investigate the predictive value of systemic serum biomarker levels for CVS and DCI following aSAH. METHODS: We retrospectively analyzed data for 450 aSAH patients admitted to University Hospital Düsseldorf between January 2011 and October 2021. Serum biomarkers were measured on admission. The occurrence of CVS and DCI was assessed based on clinical and radiological criteria. Multivariate logistic regression analysis was performed to determine the independent association of serum biomarkers with CVS and DCI. We compared the predictive values of various models using the area under the receiver operating characteristic curve. RESULTS: Of the 450 patients, 126 (28.0%) developed CVS, 123 (27.3%) developed DCI, and 62 (13.8%) developed co-occurring CVS and DCI. Patients with CVS, DCI, or both had significantly higher admission C-reactive protein (CRP) levels than those without these complications (P < 0.001). Elevated CRP levels were independently associated with an increased risk of CVS, DCI, and co-occurring CVS and DCI (P < 0.05). CRP demonstrated a higher predictive value for CVS (area under the curve [AUC]: 0.811) and co-occurring CVS and DCI (AUC: 0.802) compared to DCI alone (AUC: 0.690). CONCLUSIONS: Our findings suggest that admission systemic CRP levels can serve as a more valuable predictor for developing CVS than DCI following aSAH. Incorporating CRP into clinical assessments may aid in risk stratification and early intervention strategies for patients at high risk of these complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Li K, Khan D, Fischer I, et al. Systemic C-Reactive Protein Predicts Cerebral Vasospasm and Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Retrospective Observational Study. World Neurosurg. 2024. PMID: 39182835. doi:10.1016/j.wneu.2024.08.095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。